Your browser doesn't support javascript.
loading
Sharing lessons learnt across European cardiovascular research consortia.
de Jong, Lisette; Bobeldijk-Pastorova, Ivana; Erdmann, Jeanette; Bijker-Schreurs, Marijke; Schunkert, Heribert; Kuivenhoven, Jan Albert; van Gool, Alain J.
Afiliação
  • de Jong L; Freelance Science Journalist, Soest, Netherlands.
  • Bobeldijk-Pastorova I; Metabolic Health Research, TNO Innovation for Life, Leiden, The Netherlands.
  • Erdmann J; Institute for Cardiogenetics and University Heart Center Luebeck, University of Lübeck, Maria-Goeppert-Straße 1, 23562 Lübeck, Germany.
  • Bijker-Schreurs M; Department of Pediatrics, Molecular Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Schunkert H; Deutsches Herzzentrum München, Klinik für Herz- und Kreislauferkrankungen, Technische Universität München, and Deutsches Zentrum für Herz- und Kreislaufforschung (DZHK), 80636 Munich, Germany.
  • Kuivenhoven JA; Department of Pediatrics, Molecular Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • van Gool AJ; Metabolic Health Research, TNO Innovation for Life, Leiden, The Netherlands; Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: alain.vangool@radboudum
Drug Discov Today ; 25(4): 787-792, 2020 04.
Article em En | MEDLINE | ID: mdl-31981480
Research consortia in Europe often compete with each other for skills, human and technical resources and, eventually, recognition of the scientific impact of their work. In response to the same EU Horizon2020 call, we received funding for our research project proposals to identify and validate novel drug targets for cardiovascular disease treatment. Each consortium followed a unique and independent research strategy. However, as coordinators of these consortia we envisioned we could increase impact, outcomes and efficiency by intensifying our interaction. At an agreed stage during our projects we chose to share our knowledge, vision and ideas. In this paper we present what we learned, in the hope that future consortia will see the benefits of this approach.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Pesquisa Biomédica / Desenvolvimento de Medicamentos Tipo de estudo: Prognostic_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Pesquisa Biomédica / Desenvolvimento de Medicamentos Tipo de estudo: Prognostic_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article